TIM50 is an essential component of TIM23 complex and involved in protein translocating into the inner mitochondrial membrane. Here, we found that TIM50 was increased in breast cancer cells by SILAC. However, its biological functions and molecular mechanisms in breast cancer are poorly understood. To gain insight into the functions of TIM50 in breast cancer, we constructed two stably transfected cell lines and examined TIM50 expression in tissue samples. Our data showed that TIM50 expression was increased in breast cancer. The stable suppression of TIM50 expression through lentivirus-mediated shRNA was shown to inhibit the abilities of cancer cell proliferation and induce apoptosis. What is more, depletion of TIM50 could decrease mitochondrial membrane potential, which may be associated with cell viability. Taken together, our findings reveal a new role for TIM50 in regulating cell proliferation and apoptosis through decreasing mitochondrial membrane potential in breast cancer cell and suggest that TIM50 might be a potential target for controlling breast cancer progression.
TIM50 Cell viability Breast cancer Mitochondrial membrane potential
Translocase of inner mitochondrial membrane 50 homolog
Mitochondria membrane potential
Stable isotope labeling with amino acids in cell culture
This is a preview of subscription content, log in to check access.
This work was supported by the grants from National Natural Science Foundation of China (81472669 and 81272923).
Endo T, Yamamoto H, Esaki M. Functional cooperation and separation of translocators in protein import into mitochondria, the double-membrane bounded organelles. J Cell Sci. 2003;116:3259–67.CrossRefPubMedGoogle Scholar
Alder NN, Jensen RE, Johnson AE. Fluorescence mapping of mitochondrial TIM23 complex reveals a water-facing, substrate-interacting helix surface. Cell. 2008;134:439–50.CrossRefPubMedGoogle Scholar
Guo Y et al. Tim50, a component of the mitochondrial translocator, regulates mitochondrial integrity and cell death. J Biol Chem. 2004;279:24813–25.CrossRefPubMedGoogle Scholar
Xu X et al. Quantitative proteomics study of breast cancer cell lines isolated from a single patient: discovery of TIMM17A as a marker for breast cancer. Proteomics. 2010;10:1374–90.CrossRefPubMedGoogle Scholar
Patsialou A et al. Selective gene-expression profiling of migratory tumor cells in vivo predicts clinical outcome in breast cancer patients. Breast Cancer Res. 2012;14:R139.CrossRefPubMedPubMedCentralGoogle Scholar
Nishidate T et al. Genome-wide gene-expression profiles of breast-cancer cells purified with laser microbeam microdissection: identification of genes associated with progression and metastasis. Int J Oncol. 2004;25:797–819.PubMedGoogle Scholar
Chen X, et al. Quantitative proteomics using SILAC: principles, applications and developments. Proteomics. 2015. doi: 10.1002/pmic.201500108Google Scholar
Yamamoto H et al. Tim50 is a subunit of the TIM23 complex that links protein translocation across the outer and inner mitochondrial membranes. Cell. 2002;111:519–28.CrossRefPubMedGoogle Scholar
Meinecke M et al. Tim50 maintains the permeability barrier of the mitochondrial inner membrane. Science. 2006;312:1523–6.CrossRefPubMedGoogle Scholar
Sugiyama S et al. Involvement of the mitochondrial protein translocator component tim50 in growth, cell proliferation and the modulation of respiration in Drosophila. Genetics. 2007;176:927–36.CrossRefPubMedPubMedCentralGoogle Scholar